Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Tecan Group Ltd.. (1/11/16). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf.

Region Region San Francisco, CA
  Country United States (USA)
Organisations Organisation Tecan Group Ltd. (SIX Swiss Exchange: TECN)
  Group Tecan (Group)
  Organisation 2 J.P. Morgan Investment Management Inc.
  Group JPMorgan Chase (Group)
Products Product J.P. Morgan 34th Annual Healthcare Conference 2016 San Francisco
  Product 2 automated liquid handling technology
Index term Index term Tecan–JPMorgan Chase: investor conference, 201601 supply service Tecan Group presents at JP Morgan Healthcare Conference 2016
Persons Person Martyr, David (Tecan 201202– announced CEO for 10/12 before Leica Microsystems)
  Person 2 Brändle, Martin (Tecan 201201 Head Corporate Communications + Investor Relations)
     


The Tecan Group (SIX Swiss Exchange: TECN) today announced that it will present at the J.P. Morgan Healthcare Conference on January 14, 2016 in San Francisco, CA.

The investor presentation by David Martyr, CEO of Tecan, will begin at 9:00 am Pacific time (6:00 p.m. CET) and will be webcast live. The webcast may be accessed under the "Investor Relations" tab of Tecan's website www.tecan.com.

A replay of the webcast will be available after the presentation and will remain available for 90 days.


About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2014, Tecan generated sales of CHF 400 million (USD 437 million; EUR 331 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191).

For further information:

Tecan Group
Martin Brändle
Vice President, Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor@tecan.com
www.tecan.com

   
Record changed: 2017-07-02

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Tecan (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px